These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 15164446)

  • 21. Long-term survival of peritoneal carcinomatosis of colorectal origin.
    Verwaal VJ; van Ruth S; Witkamp A; Boot H; van Slooten G; Zoetmulder FA
    Ann Surg Oncol; 2005 Jan; 12(1):65-71. PubMed ID: 15827780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
    Pocard M; Boige V
    Bull Cancer; 2005 Feb; 92(2):151-4. PubMed ID: 15749644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study.
    Cavaliere F; Valle M; De Simone M; Deraco M; Rossi CR; Di Filippo F; Verzi S; Giannarelli D; Perri P; Pilati PL; Vaira M; Di Filippo S; Garofalo A
    In Vivo; 2006; 20(6A):747-50. PubMed ID: 17203760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited survival in the treatment of carcinomatosis from rectal cancer.
    Gomes da Silva R; Cabanas J; Sugarbaker PH
    Dis Colon Rectum; 2005 Dec; 48(12):2258-63. PubMed ID: 16228825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
    Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.
    Verwaal VJ; Boot H; Aleman BM; van Tinteren H; Zoetmulder FA
    Ann Surg Oncol; 2004 Apr; 11(4):375-9. PubMed ID: 15070596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of regional treatment for peritoneal carcinomatosis.
    Lanuke K; Mack LA; Temple WJ
    Am J Surg; 2009 May; 197(5):614-8; discussion 618. PubMed ID: 19393354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
    Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
    Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
    Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
    Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
    Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
    Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
    Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
    Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion.
    Yonemura Y; Kawamura T; Bandou E; Takahashi S; Sawa T; Matsuki N
    Br J Surg; 2005 Mar; 92(3):370-5. PubMed ID: 15739249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results].
    Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB
    Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis.
    Sayag-Beaujard AC; Francois Y; Glehen O; Sadeghi-Looyeh B; Bienvenu J; Panteix G; Garbit F; Grandclément E; Vignal J; Gilly FN
    Anticancer Res; 1999; 19(2B):1375-82. PubMed ID: 10365109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II studies: International registry of colorectal carcinomatosis.
    Gilly FN;
    Eur J Surg Oncol; 2006 Aug; 32(6):648-54. PubMed ID: 16678380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.